Peter Johannes Van Roessel, MD
Psychiatry · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Offices
- 2
- Since medical school
- 19 years
- Stanford University School of Medicine, 2007
Offices
2 locations · Stanford Health Care · 3,152 clinicians in this group
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Roessel’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence C146979 · Current
Licensed to practise in California · since 2017 · expires 2028-07-31 · Stanford University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Drugs they prescribed that Part D paid
$15,813
Pharmacies billed $15,813 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 67) in 2024. At or below the middle of the specialty; the typical psychiatry clinician is at 0%.
52 generic and 15 brand-name prescriptions · $15,813 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Auvelity | 15 | $15,219 | $1,015 |
| Fluoxetine | 16 | $64 | $4 |
Year by year
| 2024 | 67 | None | 0% (0) | 22% | $15,813 |
| 2023 | 137 | 13 | 0% (0) | None | $2,543 |
| 2022 | 115 | None | 0% (0) | None | $1,928 |
| 2021 | 217 | 15 | 0% (0) | None | $11,311 |
| 2020 | 170 | 13 | 0% (0) | None | $14,061 |
| 2019 | 239 | 19 | 0% (0) | None | $9,431 |
| 2018 | 180 | 16 | 0% (0) | None | $5,483 |
| 2017 | 96 | 12 | 0% (0) | None | $5,199 |
| 2016 | 55 | None | None | None | $680 |
| 2015 | 29 | None | 0% (0) | None | $973 |
| 2014 | 45 | None | None | 44% | $3,729 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 4 drugs
| Guanfacine Hcl Er | 38 | $590 | $16 |
| Fluoxetine | 22 | $397 | $18 |
| Duloxetine | 15 | $230 | $15 |
| Mirtazapine | 12 | $198 | $17 |
2022: 4 drugs
| Duloxetine | 30 | $369 | $12 |
| Mirtazapine | 20 | $364 | $18 |
| Risperidone | 23 | $97 | $4 |
| Trazodone | 11 | $67 | $6 |
2021: 9 drugs
| Memantine Hcl Er | 11 | $1,865 | $170 |
| Duloxetine | 36 | $1,518 | $42 |
| Mirtazapine | 40 | $942 | $24 |
| Trazodone | 16 | $262 | $16 |
| Clonazepam | 15 | $197 | $13 |
| Gabapentin | 15 | $188 | $13 |
| Fluoxetine | 13 | $105 | $8 |
| Risperidone | 14 | $85 | $6 |
| Sertraline | 12 | $50 | $4 |
2020: 7 drugs
| Memantine Hcl Er | 22 | $3,371 | $153 |
| Duloxetine | 21 | $971 | $46 |
| Mirtazapine | 22 | $220 | $10 |
| Gabapentin | 13 | $144 | $11 |
| Trazodone | 12 | $69 | $6 |
| Clonazepam | 15 | $62 | $4 |
| Sertraline | 12 | $52 | $4 |
2019: 8 drugs
| Memantine Hcl Er | 21 | $4,315 | $205 |
| Duloxetine | 41 | $1,368 | $33 |
| Mirtazapine | 20 | $547 | $27 |
| Guanfacine | 18 | $465 | $26 |
| Sertraline | 17 | $234 | $14 |
| Risperidone | 11 | $224 | $20 |
| Fluoxetine | 13 | $206 | $16 |
| Trazodone | 25 | $197 | $8 |
2018: 5 drugs
| Duloxetine | 24 | $959 | $40 |
| Memantine | 13 | $640 | $49 |
| Lithium Carbonate Er | 20 | $206 | $10 |
| Guanfacine | 16 | $129 | $8 |
| Trazodone | 23 | $112 | $5 |
2017: 2 drugs
| Bupropion Xl | 11 | $276 | $25 |
| Venlafaxine Hcl Er | 17 | $184 | $11 |
Money from drug and device companies
$91 in 2023
A payment is not proof that care is biased.
| Boehringer Ingelheim Pharmaceuticals | None | $91 | 1 payment
|
See the published payment
| Boehringer Ingelheim Pharmaceuticals | Meals · 2023-10-24 | None | $91 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1366600975
- Licence
- CA C146979, NY 250081California C146979: Current · expires 2028-07-31
- Trained
- Stanford University School of Medicine, 2007 · 19 years ago
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Psychiatry (2084P0800X)
- Mailing address
- 300 Pasteur Driver, Stanford, CA, 94305
- NPI first listed
- 2008-05-30
- NPI last updated
- 2024-04-30
- NPI record certified
- 2024-04-30
This is when the NPI record was last certified, not a medical board exam.